Tag: Over-the-Counter Drugs and Devices

The operators of a deceptive negative option scheme have agreed to a court-ordered preliminary injunction temporarily barring them from a wide range of conduct. The preliminary injunction stops the...

The Federal Trade Commission is mailing 2,897 checks totaling more than $113,000 to fully refund consumers who bought FlexiPrin, a deceptively marketed joint pain supplement. The average check amount...

Chemical Free Solutions LLC (CFS), the seller of Cedarcide Original, a line of cedar oil-based products deceptively marketed as effective at stopping and preventing bed bug infestations, has settled...

The Federal Trade Commission and the Maine Office of the Attorney General today announced a complaint and three settlements with dietary supplement marketers who allegedly used radio infomercials...

The Federal Trade Commission today announced a new “Enforcement Policy Statement on Marketing Claims for Over-the-Counter (OTC) Homeopathic Drugs.” The policy statement was informed by an FTC workshop...

According to the FTC’s complaint, between June 2013 and October 2015 the defendants marketed and sold the “Doctor Trusted” seal and certification program to websites that primarily offered health...

CORRECTED The quote in this release has been updated for clarification. Viatek Consumer Products Group, Inc. and company owner and President Lou Lentine have agreed to settle Federal Trade Commission...

The Federal Trade Commission filed an amicus brief before the U.S. Court of Appeals for the Third Circuit explaining that the district court made significant analytical errors in ruling for defendants...

The staff of the Federal Trade Commission has recommended that the U.S. Food and Drug Administration reconsider the framework it uses to regulate homeopathic medications because it may appear to...

The Federal Trade Commission has filed a joint complaint with the Florida Attorney General’s Office charging a New York-based operation known as Lifewatch with using blatantly illegal and deceptive...

FTC invites public to submit research, discussion topics, and requests to participate as panelists.